MedTrace Logo

CARTO-Finder Guided Ablation Versus Multiscale Entropy Guided Ablation in Persistent Atrial Fibrillation

NCT05454111 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2022-07-12

No results posted yet for this study

Summary

This is a randomized control trial to compare the efficacy and safety of CARTO-Finder-guided ablation plus pulmonary vein isolation versus multiscale entropy (MSE)-guided pulmonary vein isolation in patients with persistent atrial fibrillation.

Conditions

  • Persistent Atrial Fibrillation

Interventions

PROCEDURE

Multiscale entropy-guided ablation plus PVI

The multiscale entropy is calculated based on intracardiac electrical signals, higher multiscale entropy value indicates closer to the core of rotors which maintains the persistent atrial fibrillation.

PROCEDURE

CARTO-Finder-guided ablation plus PVI

CARTO-Finder-guided ablation plus PVI

Sponsors & Collaborators

  • Shandong University of Traditional Chinese Medicine

    collaborator OTHER

  • Department of Cardiology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine

    collaborator UNKNOWN

  • Wuhan Central Hospital

    collaborator OTHER

  • Department of Cardiology, Affiliated Hospital of Jining Medical University

    collaborator UNKNOWN

  • Department of Cardiology, Yuhuan Second People's Hospital

    collaborator UNKNOWN

  • Department of Cardiology, Changshu Hospital of Traditional Chinese Medicine

    collaborator UNKNOWN

  • Department of Cardiology, The PLA Navy Anqing Hospital

    collaborator UNKNOWN

  • Department of Cardiology, Jinan City People's Hospital

    collaborator UNKNOWN

  • Department of Cardiology, Xuzhou Central Hospital

    collaborator UNKNOWN

  • Shanghai Chest Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-01
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05454111 on ClinicalTrials.gov